✦ LIBER ✦

TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group

✍ Scribed by Andy Trotti; Thomas F Pajak; Clement K Gwede; Rebecca Paulus; Jay Cooper; Arlene Forastiere; John A Ridge; Deborah Watkins-Bruner; Adam S Garden; K Kian Ang; Wally Curran

Book ID: 118626437
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 149 KB
Volume: 8
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(07)70144-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of clinical trial protocols

Development of clinical trial protocols involving advanced radiation therapy techniques: The European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach

✍ A. Fairchild; R. Bar-Deroma; L. Collette; K. Haustermans; C. Hurkmans; D. Lacomb 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 304 KB

Molecular Profiling to Optimize Treatmen

Molecular Profiling to Optimize Treatment in Non-Small Cell Lung Cancer: A Review of Potential Molecular Targets for Radiation Therapy by the Translational Research Program of the Radiation Therapy Oncology Group

✍ Natalie L. Ausborn; Quynh Thu Le; Jeffrey D. Bradley; Hak Choy; Adam P. Dicker; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Prophylactic cranial irradiation for lun

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group

✍ A.H. Russell; T.E. Pajak; H.M. Selim; J.C. Paradelo; K. Murray; P. Bansal; J.D. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 869 KB

Phase I/II study of treatment of locally

Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the radiation therapy oncology group (RTOG 83-12): long-term results

✍ Mary V. Graham; Thomas E. Pajak; Arnold M. Herskovic; Bahman Emami; Carlos A. Pe 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Glufosfamide administered by 1-hour infu

Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: a phase II trial of the EORTC-New Drug Development Group

✍ G Giaccone; E.F Smit; M de Jonge; E Dansin; E Briasoulis; A Ardizzoni; J.-Y Doui 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Impact of nutrition support on treatment

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90-03

✍ Rachel Rabinovitch; Barbara Grant; Brian A. Berkey; David Raben; Kie Kian Ang; K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Background: The aim was to evaluate the relationship between nutrition support (ns) on host toxicity and cancer outcome in patients with locally advanced head and neck squamous cell carcinoma (hnscc) undergoing definitive radiotherapy (xrt). ## Methods: We performed a secondary analysis of rad